MS 275, HDAC inhibitor

  • Catalog number
    SIH-416-1MG
  • Price
    Please ask
  • Size
    1 mg
  • Stock availabilitIn Stock
    In Stock
  • CAS number
    209783-80-2
  • Description
    HDAC inhibitor
  • Molecular weight
    376,41 g/mol
  • Primary research fields
    Cell Signaling, Epigenetics, Cancer
  • Other name
    3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate, N-(2-Aminophenyl)-4-[N-(pyridine-3ylmethoxycarbonyl)aminomethyl]benzamide
  • Product category
    Small Molecules
  • Product type
    Inhibitor
  • Chemical formula
    C21H20N4O3
  • Origin
    Synthetic
  • Purity pourcentage
    >98.5
  • Soluble in
    Soluble in DMSO or methanol.
  • Physical appearance
    Off white solid
  • Storage recommendations
    -20ºC
  • Shipping recommendations
    Shipped Ambient
  • Safety information
    Classification: D1B Toxic Material Causing Immediate and SeriousToxic Effects, Toxic by ingestion, D2A Very Toxic Material Causing Other Toxic Effects, Teratogen, D2B Toxic Material Causing Other Toxic Effects, Reproductive hazard, Moderate skin irritant, Moderate eye irritant Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. Hazard statements: H301 Toxic if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H360 May damage fertility or the unborn child. Precautionary statements: P201 Obtain special instructions before use. P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
  • PubChem number
    4261
  • Scientific context
    MS 275, also referred to as Entinostat, is a benzamide histone deacetylase inhibitor. It preferentially inhibits HDAC1 and HDAC3. It is currently undergoing several clinical trials for the treatment of Hodgkin's lymphoma, advanced breast cancer, and for metastatic lung cancer.
  • Bibliography
    1. Camphausen K., Burgan W., Cerra M., Oswald K.A., Trepel J.B., Lee M.J., et al. (2004) Cancer Res. 316-21.
  • Release date
    21-May-2014
  • PubMed number
    Refer to PubMed
  • Tested applications
    To be tested
  • Tested reactivity
    To be tested
  • Representative figure legend
    Chemical structure of MS 275 (SIH-416), a HDAC inhibitor. CAS #: 209783-80-2. Molecular Formula: C21H20N4O3. Molecular Weight: 376.41 g/mol. Chemical structure of MS 275, a HDAC inhibitor (SIH-416). CAS # 209783-80-2. Molecular Formula: C21H20N4O3.
  • Warning information
    Non-hazardous
  • Country of production
    Canada
  • Total weight kg
    0.25
  • Net weight g
    0.001
  • Additional description
    Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
  • Gene target
    275   HDAC   inhibitor  
  • Gene symbol
    HDAC4, HDAC9
  • Short name
    MS 275, HDAC inhibitor
  • Alternative name
    MS 275, HDAC suppressor
Gene info
Gene info
Similar products
Filters
Contact
Chat with gentaur.com employee